|
Newly diagnosed HIV cases, n %
|
Univariate analysis
|
---|
Total with DSS/DPS1
|
With recent infection
|
OR*
|
95% CI°
|
---|
Region of origin
|
Germany
|
6,405
|
62.4%
|
2,121
|
33.1%
|
(ref)
| |
Eastern Europe
|
384
|
3.7
|
90
|
23.4%
|
0.62#
|
0.49–0.79
|
Western Europe
|
310
|
3.0
|
98
|
31.6%
|
0.93
|
0.73–1.19
|
Central Europe
|
464
|
4.5
|
143
|
30.8%
|
0.90
|
0.73–1.10
|
Asia / Oceania
|
274
|
2.7
|
65
|
23.7%
|
0.63#
|
0.47–0.83
|
America / Caribbean
|
265
|
2.6
|
68
|
25.7%
|
0.70##
|
0.53–0.92
|
North / Northeast Africa
|
90
|
0.9
|
20
|
22.2%
|
0.58##
|
0.35–0.95
|
sub-Saharan Africa
|
978
|
9.5
|
169
|
17.3
|
0.42#
|
0.35–0.50
|
Unknown region
|
88
|
0.9
|
20
|
22.7%
|
0.59##
|
0.36–0.98
|
Unknown
|
999
|
9.7
|
290
|
29.0%
|
0.83##
|
0.71–0.96
|
Region of origin (combined)
|
Germany
|
6,405
|
62.4
|
2,121
|
33.1%
|
(ref)
| |
Abroad
|
2,853
|
27.8
|
673
|
23.6%
|
0.62#
|
0.56–0.69
|
Unknown
|
999
|
9.7
|
290
|
29.0%
|
0.83##
|
0.71–0.96
|
Region of presumed infection
|
Germany
|
7,124
|
69.5
|
2,346
|
32.9%
|
(ref)
| |
Eastern Europe
|
215
|
2.1
|
41
|
19.1%
|
0.48#
|
0.34–0.68
|
Western Europe
|
205
|
2.0
|
70
|
34.1%
|
1.06
|
0.79–1.42
|
Central Europe
|
145
|
1.4
|
36
|
24.8%
|
0.67##
|
0.46–0.98
|
Asia / Oceania
|
266
|
2.6
|
54
|
20.3%
|
0.52#
|
0.39–0.70
|
America / Caribbean
|
128
|
1.2
|
30
|
23.4%
|
0.62##
|
0.41–0.94
|
North / Northeast Africa
|
43
|
0.4
|
13
|
30.2
|
0.88
|
0.46–1.70
|
sub-Saharan Africa
|
737
|
7.2
|
129
|
17.5%
|
0.43#
|
0.36–0.53
|
Unknown Region
|
64
|
0.6
|
14
|
21.9%
|
0.57
|
0.31–1.03
|
Unknown
|
1,330
|
13.0
|
351
|
26.4%
|
0.73#
|
0.63–0.83
|
Region of presumed infection (combined)
|
Germany
|
7,124
|
69.5
|
2,346
|
32.9%
|
(ref)
| |
Abroad
|
1,803
|
17.6
|
387
|
21.5%
|
0.56#
|
0.49–0.63
|
Unknown
|
1,330
|
13.0
|
351
|
26.4%
|
0.73#
|
0.64–0.83
|
- °95% CI: 95% confidence interval
- *OR: odds ratio
-
1 DSS/DPS: Dried Serum Spot/Dried Plasma Spot
- # p-value: p < =0.001
- ## p-value: p < =0.05